Diagnosis and management of Lyme neuroborreliosis

References

• Garin C, Bujadoux A. Paralysie par les tiques. J Med Lyon. 1922;71:765–767.
   Google Scholar
• Afzelius A. Erythema chronicum migrans. Acta Derm Venereol (Stockh). 1921;2:120–125.
   Google Scholar
• Pediatric_Lyme_Disease_Study_Group. Gerber MA, Shapiro ED, Burke GS, et al. Lyme disease in children in southeastern Connecticut. N Engl J Med. 1996;335(17):1270–1274.
   PubMed Web of Science ®Google Scholar
• Bannwarth A. Chronische lymphocytare meningitis, entzundliche polyneuritis und “rheumatismus”. Arch Psychiatr Nervenkr. 1941;113:284–376.
   Google Scholar
• Koedel U, Fingerle V, Pfister HW. Lyme neuroborreliosis-epidemiology, diagnosis and management. Nat Rev Neurol. 2015;11(8):446–456.
   PubMed Web of Science ®Google Scholar
• Reik L, Steere AC, Bartenhagen NH, et al. Neurologic abnormalities of Lyme disease. Medicine. 1979;58(4):281–294.
   PubMed Web of Science ®Google Scholar
• Tuerlinckx D, Bodart E, Jamart J, et al. Prediction of Lyme meningitis based on a logistic regression model using clinical and cerebrospinal fluid analysis: a European study. Pediatr Infect Dis J. 2009;28(5):394–397.
   PubMed Web of Science ®Google Scholar
• Garro AC, Rutman M, Simonsen K, et al. Prospective validation of a clinical prediction model for Lyme meningitis in children. Pediatrics. 2009;123(5):e829–34.
   PubMed Web of Science ®Google Scholar
• Cohn KA, Thompson AD, Shah SS, et al. Validation of a clinical prediction rule to distinguish Lyme meningitis from aseptic meningitis. Pediatrics. 2012;129(1):e46–53.
   PubMed Web of Science ®Google Scholar
• Luft BJ, Steinman CR, Neimark HC, et al. Invasion of the central nervous system by Borrelia burgdorferi in acute disseminated infection. Jama. 1992;267(10):1364–1367.
   PubMed Web of Science ®Google Scholar
• Rupprecht TA, Plate A, Adam M, et al. The chemokine CXCL13 is a key regulator of B cell recruitment to the cerebrospinal fluid in acute Lyme neuroborreliosis. J Neuroinflammation. 2009;6:42.
   PubMed Web of Science ®Google Scholar
• Halperin JJ. Facial nerve palsy associated with Lyme disease. Muscle & Nerve. 2003;28:516–517.
   PubMed Web of Science ®Google Scholar
• Ogrinc K, Lusa L, Lotric-Furlan S, et al. Course and outcome of early European Lyme neuroborreliosis (Bannwarth Syndrome): clinical and laboratory findings. Clin Infect Dis. 2016;63(3):346–353.
   PubMed Web of Science ®Google Scholar
• Halperin JJ, Luft BJ, Volkman DJ, et al. Lyme neuroborreliosis - peripheral nervous system manifestations. Brain. 1990;113:1207–1221.
   PubMed Web of Science ®Google Scholar
• Camponovo F, Meier C. Neuropathy of vasculitic origin in a case of Garin-Bujadoux-Bannwarth syndrome with positive borrelia antibody response. J Neurol. 1986;233:69–72.
   PubMed Web of Science ®Google Scholar
• Vallat JM, Hugon J, Lubeau M, et al. Tick-bite meningoradiculoneuritis: clinical, electrophysiologic, and histologic findings in 10 cases. Neurology. 1987;37(5):749–753.
   PubMed Web of Science ®Google Scholar
• Hopf HC. Peripheral neuropathy in acrodermatitis chronica atrophicans (Herxheimer). J Neurol Neurosurg Psychiatry. 1975;38(5):452–458.
   PubMed Web of Science ®Google Scholar
• Kristoferitsch W, Sluga E, Graf M, et al. Neuropathy associated with acrodermatitis chronica atrophicans. Clinical and morphological features. Ann N Y Acad Sci. 1988;539:35–45.
   PubMed Web of Science ®Google Scholar
• Halperin JJ, Little BW, Coyle PK, et al. Lyme disease: cause of a treatable peripheral neuropathy. Neurology. 1987;37(11):1700–1706.
   PubMed Web of Science ®Google Scholar
• Wormser GP, Strle F, Shapiro ED, et al. A critical appraisal of the mild axonal peripheral neuropathy of late neurologic Lyme disease. Diagn Microbiol Infect Dis. 2017; 87(2):163–167.
   Google Scholar
• England JD, Bohm RP, Roberts ED, et al. Mononeuropathy multiplex in rhesus monkeys with chronic Lyme disease. Ann Neurol. 1997;41(3):375–384.
   PubMed Web of Science ®Google Scholar
• Chandra A, Wormser GP, Klempner MS, et al. Anti-neural antibody reactivity in patients with a history of Lyme borreliosis and persistent symptoms. Brain Behav Immun. 2010;2010(24):1018–1024.
   Google Scholar
• Steere AC, Strle F, Wormser GP, et al. Lyme borreliosis. Nat Rev Dis Primers. 2016;2:16090.
   PubMed Web of Science ®Google Scholar
• Ackermann R, Rehse KB, Gollmer E, et al. Chronic neurologic manifestations of erythema migrans borreliosis. Ann N Y Acad Sci. 1988;539:16–23.
   PubMed Web of Science ®Google Scholar
• Mygland A, Ljostad U, Fingerle V, et al. EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol. 2010;17(1):8–16, e1–4.
   Web of Science ®Google Scholar
• Aguero-Rosenfeld ME, Nowakowski J, Bittker S, et al. Evolution of the serologic response to Borrelia burgdorferi in treated patients with culture-confirmed erythema migrans. J Clin Microbiol. 1996;34(1):1–9.
   PubMed Web of Science ®Google Scholar
• Branda JA, Linskey K, Kim YA, et al. Two-tiered antibody testing for Lyme disease with use of 2 enzyme immunoassays, a whole-cell sonicate enzyme immunoassay followed by a VlsE C6 peptide enzyme immunoassay. Clin Infect Dis. 2011;53(6):541–547.
   PubMed Web of Science ®Google Scholar
• Philipp MT, Bowers LC, Fawcett PT, et al. Antibody response to IR6, a conserved immunodominant region of the VlsE lipoprotein, wanes rapidly after antibiotic treatment of Borrelia burgdorferi infection in experimental animals and in humans. J Infect Dis. 2001;184(7):870–878.
   PubMed Web of Science ®Google Scholar
• Hammers Berggren S, Hansen K, Lebech AM, et al. Borrelia burgdorferi-specific intrathecal antibody production in neuroborreliosis: a follow-up study. Neurology. 1993;43(1):169–175.
   PubMed Web of Science ®Google Scholar
• Ljostad U, Mygland A. CSF B–lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis. J Neurol. 2008;255(5):732–737.
   PubMed Web of Science ®Google Scholar
• Rupprecht TA, Lechner C, Tumani H, et al. [CXCL13: a biomarker for acute Lyme neuroborreliosis: investigation of the predictive value in the clinical routine]. Nervenarzt. 2014;85(4):459–464.
   PubMed Web of Science ®Google Scholar
• Dattwyler RJ, Halperin JJ, Pass H, et al. Ceftriaxone as effective therapy in refractory Lyme disease. J Infect Dis. 1987;155(6):1322–1325.
   PubMed Web of Science ®Google Scholar
• Halperin JJ, Shapiro ED, Logigian EL, et al. Practice parameter: treatment of nervous system Lyme disease. Neurology. 2007;69(1):91–102.
   PubMed Web of Science ®Google Scholar
• Wormser GP, Dattwyler RJ, Shapiro ED, et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006;43:1089–1134.
   PubMed Web of Science ®Google Scholar
• Halperin J. Nervous System Lyme Disease. Current Infectious Disease Reports. 2014;17(1):1–7.
   Web of Science ®Google Scholar